Prime Medicine Inc — Cash Flow (NASDAQ:PRME) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 131.83 M165.41 M122.86 M 109.06 M Cash from investing activities 47.1 M18.71 M68.46 M 185.35 M Cash from financing activities 181.49 M655 K195.88 M 150.95 M Free cash flow 115.73 M156.69 M115.57 M 103.03 M

ニュース

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates

プライム・ドリンク・グループ、非公開株式発行の第一次クロージングを完了

Prime Drink Group completes first closing of private placement

Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond

プライム・ドリンク・グループ、最大500万ドルの資金調達に向け私募を発表

Prime Drink Group announces private placement to raise up to $5 million

ゴールドマン・サックス、プライム・メディシン株に対する初期段階バイオテク評価を再確認

Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock

Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates

Prime Medicine appoints Matthew Hawryluk as chief business officer

NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates

Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME)